Epidemic arboviral diseases: priorities for research and public health (Q28119368)

12 June 2017

Epidemic arboviral diseases: priorities for research and public health (English)

1 reference

12 June 2017

0 references

0 references

0 references

0 references

1 reference

Annelies Wilder-Smith

1

0 references

Scott C. Weaver

3

0 references

Duane J. Gubler

2

object named as

Duane J Gubler

0 references

Thomas P. Monath

4

object named as

Thomas P Monath

1 reference

12 June 2017

6

Thomas W Scott

1 reference

12 June 2017

5

David L Heymann

1 reference

12 June 2017

December 2016

0 references

20 December 2016

1 reference

Lancet Infectious Diseases

12 June 2017

2 references

12 June 2017

17

1 reference

12 June 2017

e101-e106

1 reference

12 June 2017

3

1 reference

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition

12 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Dengue/Dengue Hemorrhagic Fever: The Emergence of a Global Health Problem

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Yellow fever vaccine supply: a possible solution

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

West Nile Virus in the New World: trends in the spread and proliferation of West Nile Virus in the Western Hemisphere

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

The global distribution and burden of dengue

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Present and future arboviral threats

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Increasing Dengue Incidence in Singapore over the Past 40 Years: Population Growth, Climate and Mobility

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Geographic expansion of dengue: the impact of international travel

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Dengue fever, Hawaii, 2001-2002

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Aedes (Stegomyia) albopictus (Skuse): a potential vector of Zika virus in Singapore

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Vectorial capacity of Aedes aegypti: effects of temperature and implications for global dengue epidemic potential.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Assessing Seasonal Risks for the Introduction and Mosquito-borne Spread of Zika Virus in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

1 reference

7 January 2021

Zika virus and microcephaly: why is this situation a PHEIC?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

EPIDEMIOLOGY. Countering the Zika epidemic in Latin America

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Yellow fever cases in Asia: primed for an epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Dengue, Urbanization and Globalization: The Unholy Trinity of the 21(st) Century

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Multi-peaked adaptive landscape for chikungunya virus evolution predicts continued fitness optimization in Aedes albopictus mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Quantifying the Epidemiological Impact of Vector Control on Dengue

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

A critical assessment of vector control for dengue prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Characteristics of and factors associated with dengue vector breeding sites in the City of Colombo, Sri Lanka

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Evidence based community mobilization for dengue prevention in Nicaragua and Mexico (Camino Verde, the Green Way): cluster randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Permethrin-Treated Clothing as Protection against the Dengue Vector, Aedes aegypti: Extent and Duration of Protection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Personal Protection of Permethrin-Treated Clothing against Aedes aegypti, the Vector of Dengue and Zika Virus, in the Laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Confusion, knock-down and kill of Aedes aegypti using metofluthrin in domestic settings: a powerful tool to prevent dengue transmission?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Fractional dosing of yellow fever vaccine to extend supply: a modelling study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Efficacy of a tetravalent dengue vaccine in children in Latin America.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Population Perspectives and World Health Organization Recommendations for CYD-TDV Dengue Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Chikungunya virus and prospects for a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

The many projected futures of dengue

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

Integrating vector control across diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2816%2930518-7

7 January 2021

10.1016/S1473-3099(16)30518-7

Identifiers

DOI

1 reference

12 June 2017

1 reference

PubMed ID

28011234